Persistence of monkeypox virus DNA in clinical specimens - 29/11/22
Doi : 10.1016/j.jinf.2022.10.013
Zhaowan Li a, b, 1, Xin Xin Li b, c, 1, Yueling Chen b, d, 1, Qianqian Ruan b, e, Xiaorong Huang b, f, Guanghu Zhu a, Jiufeng Sun a, b, c, d, e, f, ⁎ 
a Guilin University of Electronic Technology, Guilin
b Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, China..óGuangdong Workstation for Emerging Infectious Disease Control and Prevention, Chinese Academy of Medical Sciences, Beijing, China
c Jinan University, Guangzhou, China
d Guangdong Pharmaceutical University, Guangzhou, China
e Sun Yat-sen University, Guangzhou, China
f Southern Medical University, Guangzhou, China
⁎Corresponding author at: Guangdong Provincial Center for Disease Control and Prevention, Guangzhou, 511430, PR China.Guangdong Provincial Center for Disease Control and PreventionGuangzhou511430PR China
Le texte complet de cet article est disponible en PDF.
Plan
© 2022
Publié par Elsevier Masson SAS.
Vol 85 - N° 6
P. 702-769 - décembre 2022 Retour au numéro
Article précédent
- Germline variants of IGHV3-53 / V3-66 are determinants of antibody responses to the BNT162b2 mRNA COVID-19 vaccine
- Yoichi Mashimo, Keiko Yamazaki, Takahiro Kageyama, Shigeru Tanaka, Toshibumi Taniguchi, Kazuyuki Matsushita, Hidetoshi Igari, Hideki Hanaoka, Koutaro Yokote, Hiroshi Nakajima, Yoshihiro Onouchi
- Efficacy and safety of fluvoxamine for the treatment of COVID-19 patients: A systematic review and meta-analysis
- Huzaifa Ahmad Cheema, Uzair Jafar, Asmaa Ahmed Elrashedy, Abia Shahid, Rehmat Ullah Awan, Muhammad Ehsan, Muhammad Ayyan, Syeda Sahra
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?